Most Approved Cancer Drugs Don’t Improve Overall Survival, Data Suggest
-
How to Prevent and Prepare for CyberattacksThe time to think about handling a cyberattack is not during an attack, according to Joyce Oh, vice president and chief information officer at Moffitt Cancer Center.
-
How Will the FTC’s Ban on Noncompete Agreements Impact Doctors and Nurses?According to the American Medical Association, around 37% to 45% of US physicians are bound by noncompete agreements.
-
Forget Ringing the Button for the Nurse. Patients Now Stay Connected by Wearing One.“The hype around a lot of these devices is they provide care at scale for less labor costs,” said Michelle Mahon.
-
April 2024: Oncology Drug ApprovalsThe FDA granted 4 first-time approvals, 5 expanded approvals, and converted 1 accelerated approval to a full approval.
-
Biden Team’s Tightrope: Reining In Rogue Obamacare Agents Without Slowing EnrollmentWashington, DC, and the 18 states that run their own ACA marketplaces have reported far fewer complaints about unauthorized enrollment and plan-switching.
Clinical Tools
Powered by
Powered by
Drug Look-up
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
Drug Comparison Charts
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
Calculators
MORE CLINICAL TOOLS
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
More From
EXPLORE OUR NETWORKRitux 3 Regimen Provides Patients With Pemphigus With Sustained Remission
Efficacy of a Co-Located Bridging Recovery Initiative for Opioid Use Disorder
US Oncologists, Hematologists Receive More Industry Payments Than Their Peers
FDA Withdraws Approval of Pepaxto for Multiple Myeloma
PIDS Updates Guidance on COVID-19 Management in Children, Adolescents
- Bladder Cancer
- Breast Cancer
- Central Nervous System Cancers
- Endocrine Cancers
- Gastrointestinal Cancers
- General Medicine
- General Oncology
- Genitourinary Cancers
- Gynecologic Cancers
- Head and Neck Cancers
- Hematologic Cancers
- Leukemia
- Lung Cancer
- Lymphoma
- Myeloma
- Pediatric Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Sarcomas
- Skin Cancers